Medicine recalls
|
| |
| The United States: U.S. Food and Drug Administration warns consumers about potential health risks from using Thorne Research’s Captomer and Captomer-250 |
| |
U.S. Food and Drug Administration (FDA) is warning consumers not to purchase or to use Thorne Research’s Captomer or Captomer-250, marketed as a dietary supplement for heavy metal toxicity and heavy metal chelation therapy. The products list DMSA (meso-2, 3-dimercaptosuccinic acid) as an active ingredient, which is contained in an FDA-approved prescription product indicated for the treatment of lead poisoning in children. FDA advises consumers to avoid all products offered over-the-counter (OTC) for chelation or detoxification. There are no FDA-approved OTC chelation products.
Procedures involving chelation agents carry significant risks and should be performed only under medical supervision. The company has received several adverse event reports associated with these products. Thorne Research has agreed to voluntarily recall the products.
FDA recommendation: Consumers should not purchase or use Captomer or Captomer-250, and avoid all products offered over-the-counter (OTC) for chelation or detoxification.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/MedWatch/../ucm401081.htm
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/ Saturday, June 14, 2014
Issued at HKT 12:45
|
| |
